3 High-Yielding Dividend Stocks That Are Trading at Dirt Cheap Prices

Source The Motley Fool

Dividend stocks trading at discounted prices can make for great investments if you're willing to be patient. That's because, assuming their payouts are sustainable, you can lock in a higher yield than normal. You may also benefit from a rising share price in the future should their valuations recover.

Three dividend stocks that are cheap buys today, offer high yields, and could be good long-term plays include AstraZeneca (NASDAQ: AZN), ExxonMobil (NYSE: XOM), and Toronto-Dominion Bank (NYSE: TD). Here's a closer look at these three stocks and why you might want to consider adding them to your portfolio.

Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every market day. Sign Up For Free »

1. AstraZeneca

Healthcare company AstraZeneca provides investors with a dividend that yields 2.2%. That's higher than the S&P 500 average of 1.3%.

While the business possesses a diverse, robust portfolio with excellent long-term growth prospects, investors have been discounting it. The stock is trading near its 52-week low of $60.47, and its forward price-to-earnings (P/E) multiple (which is based on analyst expectations) is just over 14. That's cheap when you consider the average stock in the Health Care Select Sector SPDR Fund trades at a multiple of 20 times next year's earnings.

For a company such as AstraZeneca, which has generated more than $51 billion in sales over the trailing 12 months while averaging a profit margin of around 13%, this is not just a good dividend stock but also a solid growth stock to hang on to for the long haul. The company has been building up its drug portfolio over the years through acquisitions and in-house development. There are around 200 projects in the pipeline for this growth beast in therapeutic areas, such as oncology, cardiovascular, respiratory and immunology, and others.

AstraZeneca is a stock that can be suitable for any type of investor because it checks off a lot of boxes. It's a top healthcare stock you can buy and hold for years.

2. ExxonMobil

Investors can collect a higher yield with ExxonMobil, which currently pays 3.7%. The oil and gas giant has been known for decades to be a top dividend stock. The company's annual dividend has risen annually for 42 straight years, which is an impressive feat, given the volatility that often comes with commodity prices.

Earnings will fluctuate, but this can be a great way for investors to hedge against inflation and diversify their portfolios with a top oil and gas stock. Exxon got bigger and more efficient with its acquisition of Pioneer Natural Resources last year, which doubled its overall footprint in the Permian.

Exxon's stock is cheap, given its vast operations. In the trailing 12 months, the company has posted a profit of $33.7 billion on sales totaling $339.9 billion. The stock trades at a forward P/E multiple of 12 and can give investors good value for their money.

3. Toronto-Dominion Bank

Canadian-based Toronto-Dominion Bank, also known as TD Bank, is a top dividend stock investors can buy and hold for years and even decades. At 5.2%, it provides investors with a mouthwatering yield and doesn't come with much risk, either. It has been paying a dividend since 1857.

The company faced some adversity of late as it was hit with a $3 billion charge last year in relation to lax policies relating to money laundering in the U.S., where it's a top-10 bank. As a result, it now faces restrictions on growth in the U.S. market in the near term. While that isn't great news for investors, if you're planning on holding the stock for the long term, now can be an ideal time to do so -- when the market is feeling bearish on it.

TD is still a top bank stock and will likely remain that way for the foreseeable future. It's trading at a forward P/E of 10 and is just a few dollars away from its 52-week low. While it is facing some near-term headwinds, long-term investors could benefit from buying the stock now while its valuation is low.

Should you invest $1,000 in AstraZeneca Plc right now?

Before you buy stock in AstraZeneca Plc, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and AstraZeneca Plc wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $816,504!*

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*.

See the 10 stocks »

*Stock Advisor returns as of January 13, 2025

David Jagielski has no position in any of the stocks mentioned. The Motley Fool recommends AstraZeneca Plc. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
XRP validates bullish pennant as lawyer weighs in on SEC's appeal against RippleRipple's XRP maintained a green outlook on Monday, rising more than 4% in the past week while other assets experienced a decline.
Author  FXStreet
Yesterday 01: 16
Ripple's XRP maintained a green outlook on Monday, rising more than 4% in the past week while other assets experienced a decline.
placeholder
Dogecoin Holders Are Buying Into This Crypto Priced At $0.0199 After Analysts’ $20 PredictionsDogecoin (DOGE) investors are currently on the lookout for the next big thing in the market. One project that has caught their attention is Remittix (RTX). RTX is a new altcoin that is currently trading at $0.0199. The presale success and utility of the DeFi coin could push its price to $20 soon. Meanwhile, the […]
Author  Cryptopolitan
Yesterday 06: 51
Dogecoin (DOGE) investors are currently on the lookout for the next big thing in the market. One project that has caught their attention is Remittix (RTX). RTX is a new altcoin that is currently trading at $0.0199. The presale success and utility of the DeFi coin could push its price to $20 soon. Meanwhile, the […]
placeholder
Ripple (XRP) Price Sees a Surge, Solana Targets $600 in 2025 as Investors Increase Focus on New AltcoinThe cryptocurrency market is showing renewed momentum as Ripple (XRP) experiences a significant price surge, and Solana (SOL) sets its sights on a bold $600 target by 2025. Meanwhile, a rising altcoin, Lightchain AI, is capturing investor attention with its innovative ecosystem and strong presale performance, making it a compelling choice for forward-looking investors. Ripple […]
Author  Cryptopolitan
10 hours ago
The cryptocurrency market is showing renewed momentum as Ripple (XRP) experiences a significant price surge, and Solana (SOL) sets its sights on a bold $600 target by 2025. Meanwhile, a rising altcoin, Lightchain AI, is capturing investor attention with its innovative ecosystem and strong presale performance, making it a compelling choice for forward-looking investors. Ripple […]
placeholder
Top 3 Price Prediction Bitcoin, Ethereum, Ripple: BTC & ETH rebound, XRP rallies ahead of CPI dataBitcoin (BTC) and Ethereum (ETH) prices continue to recover on Wednesday after finding support around their key levels this week.
Author  FXStreet
8 hours ago
Bitcoin (BTC) and Ethereum (ETH) prices continue to recover on Wednesday after finding support around their key levels this week.
placeholder
Gold recovers ahead of US CPI inflation dataGold’s price (XAU/USD) recovers initial weekly losses and edges higher for the second day in a row, trading in the $2,680s on Wednesday, after a softer-than-expected United States (US) Producer Price Index (PPI) release the previous day triggered substantial easing in US yields.
Author  FXStreet
2 hours ago
Gold’s price (XAU/USD) recovers initial weekly losses and edges higher for the second day in a row, trading in the $2,680s on Wednesday, after a softer-than-expected United States (US) Producer Price Index (PPI) release the previous day triggered substantial easing in US yields.
goTop
quote